Ornova Tablet 20 mg is a prescription medication containing Vonoprazan, a powerful potassium-competitive acid blocker (P-CAB) that provides rapid and sustained suppression of gastric acid. This higher-strength formulation is particularly suited for adults with moderate to severe acid-related disorders, including erosive esophagitis, peptic ulcers, and for use in combination therapy to eradicate Helicobacter pylori infection.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features and Benefits

• Active Ingredient: Each tablet contains 20 mg of Vonoprazan, offering potent and long-lasting acid suppression.
• Mechanism of Action: Vonoprazan competitively inhibits potassium ions in gastric parietal cells, effectively reducing acid secretion more rapidly and consistently than traditional proton pump inhibitors (PPIs).
• Effective Symptom Control: Provides relief from heartburn, acid reflux, and other gastrointestinal discomfort caused by excess stomach acid.
• Healing Support: Promotes faster healing of erosive esophagitis, gastric ulcers, and duodenal ulcers.
• H. pylori Eradication: When combined with appropriate antibiotics, Ornova 20 mg enhances the eradication of H. pylori, a major cause of peptic ulcers.

Usage Instructions

• Recommended Dose: Typically, 20 mg once daily, or as directed by a physician, depending on the severity of the condition.
• Administration: Can be taken with or without food. Swallow the tablet whole with water.
• Treatment Duration: Duration varies by condition; usually 4–8 weeks for ulcers or longer for chronic acid-related disorders under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety Information

• Common Side Effects: May include headache, diarrhea, constipation, nausea, or mild abdominal discomfort. Most side effects are mild and transient.
• Precautions: Not recommended for patients with severe liver dysfunction or hypersensitivity to Vonoprazan. Regular medical supervision is advised for long-term use.
• Drug Interactions: Inform your physician of all medications in use, as Vonoprazan may interact with drugs metabolized by liver enzymes.

Clinical Considerations

Ornova 20 mg is clinically proven to provide rapid, reliable, and sustained acid suppression, making it an ideal option for patients with moderate to severe acid-related disorders or those not adequately controlled by conventional PPIs. Its fast onset and consistent 24-hour acid suppression help accelerate healing and improve patient outcomes in conditions such as erosive esophagitis and H. pylori infection.